News New drugs boost Eli Lilly, ahead of animal health IPO Eli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group of recently-approved drugs.
News Merck partners Remepy in PDURS-focused alliance Merck KGaA has started working with Remepy on the development of hybrid drugs that combine medicines with digital therapeutics.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
